Roche · 1 day ago
2026 Summer Intern - AIBT
South San Francisco
Internship
Onsite
Intern
$50/hr - $50/hrRoche is a leading company in the biotechnology industry, committed to advancing science and healthcare. They are seeking a motivated summer intern to work on evaluating AI models for drug discovery, focusing on gene expression predictions and benchmarking frameworks.
BiotechnologyHealth CareHealth DiagnosticsOncologyPharmaceuticalPrecision Medicine
Responsibilities
Work on evaluating the generalization performance of foundation models for transcriptomic prediction using large-scale perturb-seq data
Implement a systematic benchmarking framework to assess how models perform on two critical challenges: predicting gene expression responses for previously unseen gene perturbations and transferring predictions across cellular contexts
Qualification
Required
You must be pursuing a PhD (enrolled student)
Statistics, Computational Biology, Bioinformatics, Computer Science, or related fields
Proficient in coding with Python
Deep knowledge of statistical principles, linear algebra, and regression analysis
Previous experience working with genomic data, especially single-cell data, is highly desirable
Preferred
Good understanding of cancer biology, and signaling pathways
Excellent communication, collaboration, and interpersonal skills
Complements our culture and the standards that guide our daily behavior & decisions: Integrity, Courage, and Passion
Benefits
Paid holiday time off benefits
Company
Roche
Roche is a pharmaceutical and diagnostics company that offers medicines and diagnostic tests for various medical conditions and diseases.
Founded in 1896
10001+ employees
H1B Sponsorship
Roche has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (12)
2024 (9)
2023 (6)
2022 (2)
2021 (2)
Funding
Current Stage
Public CompanyTotal Funding
$7.79BKey Investors
SoftBankSCALE AINovartis
2021-08-04Post Ipo Equity· $5B
2020-12-07IPO
2020-05-06Post Ipo Equity· $0.5M
Leadership Team
Alan Hippe
Member of the Executive Board - Group CFO
Christine Bakan
Global Head and VP of Software and Bioinformatics, Next Generation Sequencing
Recent News
Pharmaceutical Technology
2026-01-13
2026-01-12
Company data provided by crunchbase